Elevate Now Raises Rs 18 Cr in Seed Round Led by Physis Capital
•February 9, 2026
0
Companies Mentioned
Why It Matters
The infusion of capital positions Elevate Now to scale its medically supervised, data‑driven weight‑loss model, challenging traditional diet apps and attracting health‑focused investors. This could accelerate adoption of personalized, non‑surgical obesity treatments in India’s fast‑growing digital health market.
Key Takeaways
- •Raised Rs 18 crore seed round led by Physis Capital.
- •Total funding now exceeds $2 million plus Rs 18 crore.
- •Platform targets root-cause weight loss with medical supervision.
- •30,000+ paying users, average 10 kg loss in six months.
- •Revenue grew 17% month‑on‑month Apr 2025‑Jan 2026.
Pulse Analysis
The global obesity epidemic has turned weight management into one of the most lucrative segments of digital health. In India, rising disposable incomes and increasing awareness of metabolic diseases have spurred a wave of tech‑enabled solutions, from calorie‑counting apps to tele‑medicine platforms. Investors are keen to back models that combine clinical expertise with scalable software, as they promise higher patient adherence and better health outcomes. Against this backdrop, Elevate Now’s recent seed raise reflects broader confidence in medically supervised, data‑rich weight‑loss services.
Elevate Now differentiates itself by targeting the root causes of weight gain—insulin resistance, inflammation and hormonal imbalance—rather than relying solely on calorie restriction. Each subscriber receives a physician‑led treatment plan, continuous glucose monitoring, blood diagnostics and a dedicated health coach, all delivered through a subscription‑based, fully online interface. The Rs 18 crore infusion will fund enhancements to its AI‑driven personalization engine, expand proprietary clinical trials, and accelerate the development of proprietary supplements. These upgrades aim to improve efficacy at scale and deepen the platform’s clinical credibility.
The capital boost positions Elevate Now to compete more aggressively with established players such as HealthifyMe, SugarFit and Fittr, which largely focus on lifestyle coaching. By embedding medical supervision and evidence‑based interventions, the startup can capture a higher‑value segment of consumers willing to pay for clinically validated results. If the company sustains its reported 17% month‑on‑month revenue growth, it could set a new benchmark for subscription‑based obesity care in emerging markets, prompting further consolidation and innovation across the digital health ecosystem.
Elevate Now raises Rs 18 Cr in seed round led by Physis Capital
Elevate Now, a doctor-led, root-cause-driven clinical weight loss platform, has raised Rs 18 crore in a seed funding round led by Physis Capital along with participation from Inflection Point Ventures and Titan Capital.
The Bengaluru-based startup had earlier secured $2 million in a pre-seed funding round from W Health Ventures, Narayana Health, and Swiggy Co-founder Sriharsha Majety.
The proceeds will be deployed towards strengthening its technology platform, expanding proprietary clinical research, developing medicinal and nutritional supplements, and building next-generation personalisation systems to improve outcomes at scale, Elevate Now said in a press release.
Launched in November 2022 by Suryansh Kumar, Elevate Now is a clinical weight loss company that focuses on pioneering non-surgical, medical weight loss solutions. The startup offers personalized, science-based weight management programmes designed to help individuals achieve their fitness goals in a sustainable and responsible manner.
According to Elevate Now, it works on diagnosing underlying drivers for weight gain such as insulin resistance, inflammation and hormonal imbalances, and then delivering personalised treatment under medical supervision rather than generic calorie restriction. The platform operates a fully online, subscription-based model offering programs ranging from 3 to 24 months. Each user is assigned a physician trained in obesity medicine, supported by blood diagnostics, continuous glucose monitoring data and a dedicated health coach.
Elevate Now claims to have onboarded over 30,000 paying users to date and users have recorded an average weight loss of approximately 10 kilograms over six months. Between April 2025 and January 2026, it reported average month on month revenue growth of 17%.
It competes with the other notable players in this segment such as Healthifyme, Sugarfit, Fittr, amongst others.
0
Comments
Want to join the conversation?
Loading comments...